Introduction
The global burden of influenza is unknown but thought to be considerable. In 2008, the global estimate of influenzaassociated severe acute lower respiratory illness in children <5 years was 1 million cases, 1 and the World Health Organization (WHO) suggests that 3-5 million severe cases occur in persons of all ages each. 2 In temperate regions, influenza usually causes annual outbreaks during the winter season (November-March in the Northern Hemisphere and June-September in the Southern Hemisphere). 3, 4 In contrast, influenza-associated mortality in subtropical or tropical regions, particularly in developing countries, remains poorly quantified and often underestimated. The pattern of influenza epidemics in tropical regions is less distinct and more diffuse. Seasonal influenza epidemics can sometimes occur twice or more throughout a year. 5 The exact burden of influenza morality is difficult to estimate, and the challenges in counting influenza-associated deaths include the following: testing of hospital patients for influenza (particularly in elderly persons) is uncommon, influenza is rarely specifically recorded on death certificates, and many deaths that may be causally related to influenza occur after virus can be detected. Therefore, estimation of influenza-associated deaths or hospitalizations often relies on statistical modeling rather than on direct measurement. Various methodological approaches have been used to estimate the excess deaths associated with the circulation of influenza virus in temperate region. [6] [7] [8] [9] [10] However, the best approach for modeling influenza in tropical regions is unclear. Further, although there are results for wealthy, tropical countries (e.g., Singapore), 11 the findings may be different from Thailand, where the severity of infections may be compounded by a higher prevalence of underlying illness or other factors.. In this study, we used a regression model to examine the impact of influenza, by virus type and subtype, on deaths in Thailand, while adjusting for potential confounding effects by other co-circulating influenza virus subtypes.
Estimating the burden of influenza mortality is important to help guide vaccination programs, evaluate the use of diagnostic tests and antiviral drugs, and plan for seasonal epidemics and future pandemics. In this analysis, we applied a negative binomial model to the weekly counts of deaths and viral data to explore the seasonal effect of influenza on mortality and provided estimates of excess mortality associated in Thailand by death category, age group, and influenza subtypes for the years 2006 through 2011.
Methods

Mortality data
Weekly electronic mortality data for years 2006 through 2011 were obtained from the Bureau of Policy and Strategy, Ministry of Public Health (MoPH), Thailand. Deaths were categorized into three groups based on codes from the International Classification of Diseases, Tenth Revision [ICD-10]: circulatory diseases (ICD-10 codes I00-99), respiratory diseases (ICD-10 codes J00-99), and pneumonia and influenza (P&I) (ICD-10 codes J10-18). Other variables included age at death and location of death (hospital or community). We defined non-pandemic years as every year except 2009.
Viral surveillance data
In 2004, the National Institute of Health, MoPH launched the national influenza sentinel surveillance system to monitor virus circulation in patients with influenza-like illness presenting at outpatient clinics in 11 sites throughout Thailand. 12 Between 2004 and 2009, each site was first instructed to enroll a convenience sample of up to five patients per week with ILI for a total of 20 patients per month. In September 2009, the sample size was increased to 10 patients per week (five from children aged <15 years and five from persons aged ≥ 15 years). These data, collected systematically throughout the year, represent an unbiased sample of the timing of influenza activity and are appropriate for analyzing seasonal trends. All specimens were tested by reserve-transcription polymerase chain reaction for influenza viruses. We obtained the weekly numbers of influenza viruses (by type and subtype) and the total number of specimens tested, from the National Institute of Health, and calculated weekly positivity using weekly number of specimens as the denominator.
Reapportioning mortality data
Of all-cause deaths among person aged <65 and ≥65 years, ill-defined deaths (i.e., no cause listed) accounted for 25% (58% of these occurred in the community) and 54% (87% occurred in the community), respectively. To account for the high proportion of ill-defined cause of death, we reapportioned weekly ill-defined deaths by age (<65 and ≥65 years), and location (hospital and community) to the various categories (P&I, respiratory, circulatory). We first excluded the ill-defined deaths and calculated the proportion of deaths due to P&I, respiratory and circulatory among deaths recorded in-hospital by age (<65 and ≥65 years) under the assumption that the coding for an in-hospital death was more accurate than for a community death. This assumption is based on the knowledge that deaths occurring outside the hospital are recorded by non-medical, civil registrars and based on lay reports from relatives. 13 We then reapportioned all ill-defined deaths (including both those that occurred inhospital and those in the community) to the various categories (P&I, respiratory, circulatory) so that the final proportion in each category were equivalent to those found in the in-hospital deaths.
We created two separated databases, one without reapportioning the deaths and the other with reapportioning.
Climate data
Meteorological parameters including weekly mean temperature and absolute humidity were obtained from the Thai Meteorological Department.
Negative binomial regression model
A negative binomial regression model was used to estimate deaths attributable to influenza in two age groups (<65 and ≥65 years) by incorporating influenza viral data as covariates in the model. To assume an additive relationship between the exposure to influenza and resulting mortality, we used an identity link function in the models. The models included independent variables that comprised weekly percentage of specimens testing of confirmed infection with seasonal influenza A, seasonal influenza B, and influenza A (H1N1) pdm09 during a given week. We tested various lags (no lag, 1 week, and 2 weeks) to account for delays between infection and death. To account for the baseline, the models include either harmonic terms for annual [sine (h) and cosine (h), where h = 2*p*week/52Á25] and semiannual [sine (2h) and cosine (2h)] periods or climate factors [weekly mean temperature and absolute humidity, using linear terms or nonlinear terms (natural cubic spline function)]. Selection of the most statistically meaningful proxy for influenza activity was based on fitting 13 models to ≥65 years respiratory deaths and comparing Akaike information criterion (AIC) values. We obtained the smallest AIC values for a model with a 2-week lag and smoothing spline of temperature and humidity and report those results. A detailed description of the model fitting procedure is provided in Table S1 .
In this model,
Influenza-associated mortality in Thailand where Y t is the number of deaths in week t and a is the offset term and is equal to the log of the population size. b 0 represented the intercept, b 1 and b 2 represented coefficients associated with secular trends, b 3 represented coefficients associated with a natural cubic spline (NCS) of weekly mean temperature, b 4 represented coefficients associated with a NCS of absolute humidity, b 5 -b 9 represented coefficients associated with the percentages of specimens testing positive for each influenza virus type and subtype during a given week. All viral terms had a 2-week lag. The models were run separately by death category (P&I, respiratory, and circulatory), age group (<65 and ≥65 years), and location of death (hospital or community, only for the data without reapportioned deaths). The analysis was conducted both ways, with and without reapportioning these deaths with the latter included as supplementary tables and figures.
To estimate excess mortality associated with influenza, we used the following procedure: 1. Calculate the expected mortality with the full model (E0). 2. Calculate expected mortality with the same fitted model, but the influenza terms were set as zero (E1). E0-E1 was the estimate of mortality due to influenza. Confidence intervals were calculated based on the standard errors of model coefficients. We note that these confidence intervals provide only a minimum estimate of uncertainty.
The statistical analyses were carried out using SAS version 9.3 (SAS Institute, Cary, NC, USA).
Sensitivity analysis
As a sensitivity analysis, we modeled all-cause deaths. We compared the excess deaths obtained using the all-cause deaths as outcome in the final models with estimates using respiratory and circulatory deaths as outcomes in the same models. occurred in Thailand (42% occurred in hospital). An average of 13 554 (3Á4%) underlying P&I deaths, 27 268 (6Á8%) underlying respiratory deaths, and 37 112 (9Á3%) underlying circulatory deaths occurred each year. Table 1 shows the annual mean number and proportion of deaths by cause of death. Forty-one percent of total deaths were coded as cause ill-defined and redistributed to the various categories (P&I, respiratory, circulatory) by location and age group.
Results
Mortality data
Viral surveillance data
During the 6-year period, 21 560 specimens were tested for influenza viruses. There were 2961 (14%) positive results for influenza viruses. The annual mean number of tests positive was 14% (range 10-18%) for influenza A viruses, and 6Á5% (range 4Á1-10%) for influenza B viruses (Table S2 ).
Estimates of influenza-associated deaths
For all ages combined, there was year-to-year variability in the annual number of influenza-associated deaths; the mean for all years was 2511 (4Á0 per 100 000) ( Table 2 ). The average influenza-associated mortality rate for non-pandemic years was 4Á3 per 100 000, and for the pandemic year, 2009, it was 2Á4 per 100 000. The rates in pandemic year for both age groups were lower compared with the other years (<65 years: 0Á6 versus 0Á7 per 100 000 and ≥65 years: 24 versus 26 per 100 000). The annual death rate attributable to influenza was the highest in the year 2008 (5Á6). Eighty-three percent (2094/2511) of the average annual estimated influenza-associated deaths occurred among person age ≥65 years. The average annual rate of influenza-associated deaths was 0Á7 per 100 000 population for person aged <65 years and 42 for person aged ≥65 years. Among adults aged <65 years and ≥65 years, influenza A (H3N2) and B were associated with the most deaths. The average annual number of influenzaassociated deaths was 1401 (2Á2 per 100 000) for underlying P&I causes, 2751 (4Á3 per 100 000) for underlying respiratory causes, and 529 (0Á8 per 100 000) for underlying circulatory causes (Table 3) . Deaths among persons aged ≥65 years accounted for 74% (1031/1401), 76% (2094/2751), and 100% (529/529) of the overall estimated average annual influenzaassociated deaths with underlying P&I, respiratory, and circulatory causes, respectively. The average annual rate of influenza-associated deaths for adults aged ≥65 years was 21 per 100 000 persons for P&I deaths, 42 per 100 000 for respiratory deaths, and 11 per 100 000 for circulatory deaths (Table 3) . Among adults aged <65 years, the average annual rate of influenza-associated deaths was 0Á6 deaths per 100 000 persons for P&I causes and 1Á1 per 100 000 for respiratory causes. The weekly number of deaths from 2006 to 2011, and excess deaths where mortality exceeded the baseline, is shown in Figure 1 ; there are no discrete peaks indicating influenza epidemics. In the sensitivity analysis of all-cause deaths, the average annual rate of influenza-associated deaths was 2Á0 (95%CI: À24 to 27) per 100 000 population for person aged <65 years and 99 (95% CI: À322 to 516) for person aged ≥65 years.
Estimates of influenza-associated deaths without reapportion ill-defined death
Estimated mean annual influenza-associated deaths without reapportioning ill-defined death are shown in Table S3 . The average annual number of influenza-associated deaths from underlying P&I, respiratory, and circulatory diseases was 632 (1Á0 per 100 000), 1308 (2Á1 per 100 000), and 295 (0Á5 per 100 000, Table S4 ), respectively. The estimated number of influenza deaths from the model with reapportioned illdefined deaths and from the non-reapportion model for persons aged <65 was similar, while for those age ≥ 65 years, the estimates from reapportioned models were approximately 3 times higher than from the non-reapportion model. Compared with Figure 1 , similar patterns were observed with no obvious peak for the excess circulatory and respiratory deaths and overall lower magnitude ( Figure S1 ).
Discussion
Influenza was associated with excess death in Thailand, and the estimated excess mortality was considerable (average 4Á0 per 100 000 persons), with 83% of the influenza-associated deaths among persons ≥65 years. The estimated annual excess morality in persons ≥65 years was 42 per 100 000 persons. These finding are similar, but slightly lower than those from a recent study in Thailand that used a Bayesian model to estimate excess mortality due to seasonal influenza; this study found an estimated 6Á1 annual excess deaths per 100 000 population and 68 per 100 000 among person ≥60 years.
14 Reasons for the differences could be due to the use of different outcomes for the models; Copper and colleagues use all-cause mortality, whereas we focused on respiratory and circulatory deaths. In addition, it could also be the results of the slightly different years of data analyzed, the use of three instead of two age groups in the model, or the use of the Bayesian model.
Our estimates of annual influenza-associated underlying P&I, underlying respiratory and underlying circulatory deaths in Thailand for the all-ages group were two times lower than the estimates of excess influenza deaths observed in tropical Singapore, 11 subtropical Hong Kong, 15 and temperate United States. 16 When looking by age, we observe that the decreased rates in elderly persons account for these country-specific differences. Some of these differences may be explained by the different age distribution in these countries; Hong Kong has a higher percentage of the population ≥65 years (14%) compared with Thailand (9Á8%) or Singapore (8Á1%). 17 In Thailand, the proportion of influenza-associated deaths was higher among the elderly (persons ≥65 years), which is consistent with data from Hong Kong and the United States where >80% of influenzaassociated deaths occurred among the elderly. 15, 16 However, our estimates for influenza-associated deaths in persons age ≥65 years were consistently lower than those in Singapore (46Á9 per 100 000 for P&I, and 155Á4 per 100 000 for circulatory and respiratory) and Hong Kong (39Á3 per 100 000 for P&I and 102 per 100 000 for circulatory and respiratory). 11, 15 We suspect that our rates in elderly may be an underestimation resulting from inaccurate coding of death; the high proportion of ill-defined causes of death in our data set support this theory. 13 Other factors that might have contributed to the differences in mortality impact between countries include geographical differences, age distribution, previous influenza exposure history of the population, influenza vaccination coverage, use of antiviral drugs, access to health care, and use of public health mitigation strategies. To address the issue of the high proportion of ill-defined causes of deaths in our data set, we performed a sensitivity analysis. We modeled all-cause deaths as outcome and our estimate (99 per 100 000, 95%CI: À322 to 516) for influenza-associated deaths in persons age ≥65 years was more comparable with the estimate in Singapore (167Á8 (95% CI: 107Á0-229Á5) for all-cause) and the estimate in Hong Kong (136Á1 (95% CI: 83Á7-188Á4) for all-cause).
Although there were peaks in influenza-associated mortality in Thailand during 2006 through 2011, they were not consistent in their timing. This is in contrast to trends observed in temperate climates and likely reflects the yearround circulation of influenza viruses which may attenuate any seasonal mortality pattern. The majority of deaths from seasonal influenza occurred among people aged 65 year or older, but in the pandemic, the proportion of deaths among younger persons increased. This may suggest that there was some immunologic protection in persons who were exposed to A(H1N1) viruses before the 1957 pandemic, as has been demonstrated in other countries. 18, 19 Our estimates of influenza-associated deaths have several methodological limitations. First, the quality of mortality statistics in Thailand was considered poor because a large proportion had a poorly defined cause of death. 13, 20 Further, the validity of the cause of death statistics was questionable as many out-of hospital deaths were coded by persons not medically qualified to determine the cause of death. 21 Thus, misclassification of cause of death may have resulted in an underestimate of our specific mortality outcomes of interest, particularly in our excess mortality results that did not reapportion the ill-defined cause of death. Second, the relative distribution of influenza A and B viruses is known to vary by age, but the viral surveillance data were not robust enough to stratify by age and provide meaningful estimates by age group. Third, with only one cause of death listed, we were unable to assess contributing causes of death. 21 These data are important to help guide the introduction of prevention strategies, such as seasonal influenza vaccination. Despite the widespread adoption of seasonal influenza vaccine recommendations in middle-income countries that have sufficient economic and public health resources to support vaccination programs, in Thailand seasonal influenza vaccine has been administered to <1% of the population annually and does not meet the need of the identified target groups. 22 As vaccine use continues to increase, mortality should be monitored to assess the impact of the vaccination campaign.
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